Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-59281.69%
operating margin TTM
-49202.88%
revenue TTM
1.96 Million
revenue per share TTM
0.04$
valuation ratios | |
|---|---|
| pe ratio | -0.91 |
| peg ratio | -0.01 |
| price to book ratio | -12.74 |
| price to sales ratio | 554.01 |
| enterprise value multiple | -1.21 |
| price fair value | -12.74 |
profitability ratios | |
|---|---|
| gross profit margin | -732.25% |
| operating profit margin | -49202.88% |
| pretax profit margin | -59281.69% |
| net profit margin | -59281.69% |
| return on assets | -155.79% |
| return on equity | -307.59% |
| return on capital employed | 20471.67% |
liquidity ratios | |
|---|---|
| current ratio | 0.79 |
| quick ratio | 0.79 |
| cash ratio | 0.52 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 1,958.93 |
| days of payables outstanding | 1,419.92 |
| cash conversion cycle | 539.01 |
| receivables turnover | 0.19 |
| payables turnover | 0.26 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.14 |
| debt equity ratio | -1.30 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 4.36 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -8.87 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.71 |
| cash per share | 0.97 |
| operating cash flow per share | -1.70 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -8.87 |
| short term coverage ratios | -32.47 |
| capital expenditure coverage ratio | -561.90 |
Frequently Asked Questions
When was the last time Inovio Pharmaceuticals, Inc. (NASDAQ:INO) reported earnings?
Inovio Pharmaceuticals, Inc. (INO) published its most recent earnings results on 10-11-2025.
What is Inovio Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Inovio Pharmaceuticals, Inc. (NASDAQ:INO)'s trailing twelve months ROE is -307.59%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Inovio Pharmaceuticals, Inc. (INO) currently has a ROA of -155.79%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did INO's net profit margin stand at?
INO reported a profit margin of -59281.69% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is INO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.79 in the most recent quarter. The quick ratio stood at 0.79, with a Debt/Eq ratio of -1.30.